APG Asset Management N.V. Has $17.34 Million Stake in Waters Corporation $WAT

Key Points

• APG Asset Management N.V. reduced its stake in Waters Corporation by 6.1% during the 1st quarter, ending up with 50,817 shares worth approximately $17.3 million.
• Waters Corporation reported earnings of $2.95 per share for the last quarter, exceeding analysts' expectations and showing an 8.8% year-over-year revenue increase.
• Equities analysts have a consensus rating of "Hold" for Waters Corporation, with an average target price of $378.73.

APG Asset Management N.V. lessened its stake in shares of Waters Corporation (NYSE:WAT - Free Report) by 6.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 50,817 shares of the medical instruments supplier's stock after selling 3,327 shares during the quarter. APG Asset Management N.V. owned about 0.09% of Waters worth $17,339,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Olde Wealth Management LLC bought a new position in Waters in the 1st quarter worth approximately $25,000. Zions Bancorporation National Association UT bought a new stake in shares of Waters in the 1st quarter worth approximately $28,000. IFP Advisors Inc increased its holdings in Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock valued at $30,000 after buying an additional 44 shares during the period. Whipplewood Advisors LLC raised its position in Waters by 5,200.0% in the first quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 104 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in Waters during the first quarter valued at approximately $41,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Analysts Set New Price Targets

WAT has been the subject of a number of recent analyst reports. UBS Group reiterated a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on shares of Waters and gave the company a "hold" rating in a research note on Tuesday, August 5th. Wells Fargo & Company reduced their target price on Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a report on Tuesday, August 5th. Jefferies Financial Group set a $385.00 price objective on shares of Waters and gave the company a "buy" rating in a research report on Monday, August 4th. Finally, Scotiabank reaffirmed a "sector outperform" rating and issued a $465.00 price target on shares of Waters in a research note on Friday, July 11th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Waters currently has an average rating of "Hold" and an average price target of $378.73.

Waters Stock Performance

WAT stock traded up $2.69 during trading hours on Thursday, reaching $297.32. The stock had a trading volume of 707,192 shares, compared to its average volume of 613,268. The stock has a 50-day simple moving average of $311.52 and a 200 day simple moving average of $340.20. The stock has a market capitalization of $17.70 billion, a PE ratio of 26.81, a price-to-earnings-growth ratio of 2.76 and a beta of 1.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56.

Waters (NYSE:WAT - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. During the same period last year, the firm posted $2.63 earnings per share. The business's revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Analysts predict that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.